CAPTRUST Financial Advisors

CAPTRUST Financial Advisors’s Palvella Therapeutics PVLA Stock Holding History

CAPTRUST Financial Advisors’s Portfolio PVLA Stock Details PVLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$443K	Buy	+3,557	New	+$371K	﹤0.01%	2115
2022 Q3	–	Sell	-13	Closed	-$2K	–	4167
2022 Q2	$2K	Hold	13	–	–	﹤0.01%	4531
2022 Q1	$3K	Hold	13	–	–	﹤0.01%	4402
2021 Q4	$4K	Hold	13	–	–	﹤0.01%	4207
2021 Q3	$5K	Hold	13	–	–	﹤0.01%	3969
2021 Q2	$4K	Hold	13	–	–	﹤0.01%	3971
2021 Q1	$3K	Hold	13	–	–	﹤0.01%	3951
2020 Q4	$2K	Hold	13	–	–	﹤0.01%	3172
2020 Q3	$2K	Hold	13	–	–	﹤0.01%	2822
2020 Q2	$3K	Buy	+13	New	+$3.04K	﹤0.01%	2533
2019 Q4	–	Sell	-6	Closed	-$2K	–	1856
2019 Q3	$2K	Hold	6	–	–	﹤0.01%	1819
2019 Q2	$2K	Buy	+6	New	+$1.79K	﹤0.01%	1829

Other funds holding PVLA

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return